1. Home
  2. AQST vs JMSB Comparison

AQST vs JMSB Comparison

Compare AQST & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • JMSB
  • Stock Information
  • Founded
  • AQST 2004
  • JMSB 2005
  • Country
  • AQST United States
  • JMSB United States
  • Employees
  • AQST N/A
  • JMSB N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • AQST Health Care
  • JMSB Finance
  • Exchange
  • AQST Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • AQST 272.9M
  • JMSB 264.6M
  • IPO Year
  • AQST 2018
  • JMSB N/A
  • Fundamental
  • Price
  • AQST $4.02
  • JMSB $18.50
  • Analyst Decision
  • AQST Strong Buy
  • JMSB
  • Analyst Count
  • AQST 7
  • JMSB 0
  • Target Price
  • AQST $11.29
  • JMSB N/A
  • AVG Volume (30 Days)
  • AQST 1.3M
  • JMSB 23.0K
  • Earning Date
  • AQST 08-05-2025
  • JMSB 07-23-2025
  • Dividend Yield
  • AQST N/A
  • JMSB 1.62%
  • EPS Growth
  • AQST N/A
  • JMSB 475.76
  • EPS
  • AQST N/A
  • JMSB 1.24
  • Revenue
  • AQST $54,228,000.00
  • JMSB $54,782,000.00
  • Revenue This Year
  • AQST N/A
  • JMSB N/A
  • Revenue Next Year
  • AQST $45.71
  • JMSB N/A
  • P/E Ratio
  • AQST N/A
  • JMSB $15.03
  • Revenue Growth
  • AQST 5.29
  • JMSB 50.81
  • 52 Week Low
  • AQST $2.12
  • JMSB $13.81
  • 52 Week High
  • AQST $5.80
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • AQST 73.02
  • JMSB 50.98
  • Support Level
  • AQST $3.62
  • JMSB $18.60
  • Resistance Level
  • AQST $4.19
  • JMSB $19.99
  • Average True Range (ATR)
  • AQST 0.19
  • JMSB 0.45
  • MACD
  • AQST 0.04
  • JMSB -0.08
  • Stochastic Oscillator
  • AQST 83.96
  • JMSB 10.24

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: